Published in N Engl J Med on August 11, 2005
The metabolic syndrome. Endocr Rev (2008) 5.33
Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab (2009) 5.02
Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med (2007) 3.18
Network-based analysis of affected biological processes in type 2 diabetes models. PLoS Genet (2007) 2.54
Nuclear Receptors, RXR, and the Big Bang. Cell (2014) 2.22
Energetics, epigenetics, mitochondrial genetics. Mitochondrion (2009) 2.08
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats. J Lipid Res (2009) 1.96
Nuclear receptors: decoding metabolic disease. FEBS Lett (2007) 1.95
Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality. J Clin Invest (2007) 1.85
Nuclear receptors, mitochondria and lipid metabolism. Mitochondrion (2008) 1.71
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol (2006) 1.70
Thyroid hormone regulation of metabolism. Physiol Rev (2014) 1.70
Expression of peroxisome proliferator-activated receptor-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis. Endocrinology (2008) 1.49
Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res (2011) 1.42
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans. Proc Natl Acad Sci U S A (2007) 1.37
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. Am J Hum Genet (2007) 1.36
Receptor interacting protein 140 regulates expression of uncoupling protein 1 in adipocytes through specific peroxisome proliferator activated receptor isoforms and estrogen-related receptor alpha. Mol Endocrinol (2007) 1.32
Bile acid transporters in health and disease. Xenobiotica (2008) 1.24
Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation. Trends Endocrinol Metab (2009) 1.22
Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer. PLoS Med (2010) 1.19
Corepressor SMRT promotes oxidative phosphorylation in adipose tissue and protects against diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A (2011) 1.16
Research resource: transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells. Mol Endocrinol (2010) 1.15
Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma. J Biol Chem (2010) 1.14
Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. Am J Transl Res (2010) 1.10
Carotenoid metabolism in mammals, including man: formation, occurrence, and function of apocarotenoids. J Lipid Res (2013) 1.07
Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation. Trends Neurosci (2006) 1.04
On the role of skin in the regulation of local and systemic steroidogenic activities. Steroids (2015) 1.01
PPAR-gamma in the Cardiovascular System. PPAR Res (2008) 1.01
Regulation of retinal dehydrogenases and retinoic acid synthesis by cholesterol metabolites. EMBO J (2006) 1.00
Shift work and its effects on the cardiovascular system. Cardiovasc J Afr (2008) 0.97
Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors. Genes Nutr (2006) 0.96
IGFBP-3, hypoxia and TNF-alpha inhibit adiponectin transcription. Biochem Biophys Res Commun (2009) 0.96
The transcription factor ultraspiracle influences honey bee social behavior and behavior-related gene expression. PLoS Genet (2012) 0.95
A protein interaction atlas for the nuclear receptors: properties and quality of a hub-based dimerisation network. BMC Syst Biol (2007) 0.94
Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1beta-mediated reduction and modification of murine hepatic nuclear retinoid X receptor alpha. J Hepatol (2009) 0.93
Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome. PPAR Res (2007) 0.92
Suppression of nitric oxide induction and pro-inflammatory cytokines by novel proteasome inhibitors in various experimental models. Lipids Health Dis (2011) 0.91
Hepatic drug transporters and nuclear receptors: regulation by therapeutic agents. World J Gastroenterol (2008) 0.90
Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice. Lipids Health Dis (2011) 0.89
Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology (Berl) (2008) 0.89
Screening for ligands of human retinoid X receptor-alpha using ultrafiltration mass spectrometry. Anal Chem (2007) 0.88
A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways. J Lipids (2012) 0.87
Chronic alcohol intake upregulates hepatic expression of carotenoid cleavage enzymes and PPAR in rats. J Nutr (2010) 0.87
Nuclear hormone retinoid X receptor (RXR) negatively regulates the glucose-stimulated insulin secretion of pancreatic ß-cells. Diabetes (2010) 0.87
Elk1 and SRF transcription factors convey basal transcription and mediate glucose response via their binding sites in the human LXRB gene promoter. Nucleic Acids Res (2007) 0.86
High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome. Pharmacogenomics J (2010) 0.85
The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects. PPAR Res (2008) 0.85
Inhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule. Evid Based Complement Alternat Med (2013) 0.84
Application of computational approaches to study signalling networks of nuclear and Tyrosine kinase receptors. Biol Direct (2010) 0.84
Peroxisome proliferator-activated receptor genetic polymorphisms and nonalcoholic Fatty liver disease: any role in disease susceptibility? PPAR Res (2013) 0.84
Pharmacological manipulation of the RAR/RXR signaling pathway maintains the repopulating capacity of hematopoietic stem cells in culture. Mol Endocrinol (2008) 0.84
(+)-Rutamarin as a dual inducer of both GLUT4 translocation and expression efficiently ameliorates glucose homeostasis in insulin-resistant mice. PLoS One (2012) 0.83
Regulation of adipogenesis by nuclear receptor PPARγ is modulated by the histone demethylase JMJD2C. Genet Mol Biol (2011) 0.83
Liver X receptor regulation of thyrotropin-releasing hormone transcription in mouse hypothalamus is dependent on thyroid status. PLoS One (2014) 0.83
Transcriptome profiling and genome-wide DNA binding define the differential role of fenretinide and all-trans RA in regulating the death and survival of human hepatocellular carcinoma Huh7 cells. Biochem Pharmacol (2013) 0.83
Function annotation of hepatic retinoid x receptor α based on genome-wide DNA binding and transcriptome profiling. PLoS One (2012) 0.83
Structural mechanism for signal transduction in RXR nuclear receptor heterodimers. Nat Commun (2015) 0.83
Sexually dimorphic genome-wide binding of retinoid X receptor alpha (RXRα) determines male-female differences in the expression of hepatic lipid processing genes in mice. PLoS One (2013) 0.82
All-trans retinoic acid regulates hepatic bile acid homeostasis. Biochem Pharmacol (2014) 0.82
Hexarelin Signaling to PPARgamma in Metabolic Diseases. PPAR Res (2008) 0.82
Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity. Cardiovasc Diabetol (2008) 0.81
Diverse coactivator recruitment through differential PPARγ nuclear receptor agonism. Genet Mol Biol (2013) 0.81
Inflammatory mediators increase SUMOylation of retinoid X receptor α in a c-Jun N-terminal kinase-dependent manner in human hepatocellular carcinoma cells. Mol Pharmacol (2013) 0.81
The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products. PPAR Res (2008) 0.81
PPAR Medicines and Human Disease: The ABCs of It All. PPAR Res (2012) 0.79
Enhanced gastrointestinal expression of cytosolic malic enzyme (ME1) induces intestinal and liver lipogenic gene expression and intestinal cell proliferation in mice. PLoS One (2014) 0.79
Characterization of a molecular switch system that regulates gene expression in mammalian cells through a small molecule. BMC Biotechnol (2010) 0.79
Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liver. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.79
Comparative analysis of acute and chronic corticosteroid pharmacogenomic effects in rat liver: transcriptional dynamics and regulatory structures. BMC Bioinformatics (2010) 0.79
Effect of high versus low doses of fat and vitamin A dietary supplementation on fatty acid composition of phospholipids in mice. Genes Nutr (2013) 0.79
Association of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype Analysis. J Lipids (2013) 0.79
Retinoid X receptor heterodimers in the metabolic syndrome. N Engl J Med (2005) 0.78
Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs. Int J Med Chem (2017) 0.78
Thiazolidinediones and hepatic fibrosis: don't wait too long. Gut (2006) 0.77
Increased systemic glucose tolerance with increased muscle glucose uptake in transgenic mice overexpressing RXRγ in skeletal muscle. PLoS One (2011) 0.77
Combination antiretroviral therapy and chronic HIV infection affect serum retinoid concentrations: longitudinal and cross-sectional assessments. AIDS Res Ther (2012) 0.76
Lipodystrophy, Diabetes and Normal Serum Insulin in PPARγ-Deficient Neonatal Mice. PLoS One (2016) 0.75
Discovery of a Potent Retinoid X Receptor Antagonist Structurally Closely Related to RXR Agonist NEt-3IB. ACS Med Chem Lett (2011) 0.75
Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In Vivo. PPAR Res (2011) 0.75
Effects of LG268 on Cell Proliferation and Apoptosis of NB4 Cells. Int J Med Sci (2016) 0.75
Vitamin A deficiency results in dysregulation of lipid efflux pathway in rat kidney. Pediatr Nephrol (2010) 0.75
Design and synthesis of boron containing potential pan-RAR inverse agonists. Tetrahedron Lett (2012) 0.75
Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients. Adv Biomed Res (2016) 0.75
Reduced adiponectin expression after high-fat diet is associated with selective up-regulation of ALDH1A1 and further retinoic acid receptor signaling in adipose tissue. FASEB J (2016) 0.75
Profile of David J. Mangelsdorf. Proc Natl Acad Sci U S A (2010) 0.75
Differential Regulation of Bcl-xL Gene Expression by Corticosterone, Progesterone, and Retinoic Acid. J Biochem Mol Toxicol (2016) 0.75
NSC-640358 acts as RXRα ligand to promote TNFα-mediated apoptosis of cancer cell. Protein Cell (2015) 0.75
Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci (2016) 0.75
Transcriptional coordination of hepatic autophagy by nutrient-sensing nuclear receptor PPARα and FXR. Ann Pediatr Endocrinol Metab (2016) 0.75
Retinoid X Receptors Intersect the Molecular Clockwork in the Regulation of Liver Metabolism. Front Endocrinol (Lausanne) (2017) 0.75
Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study. Oncol Lett (2016) 0.75
Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab (2007) 9.62
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab (2005) 9.14
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med (2003) 6.21
Nuclear receptor expression links the circadian clock to metabolism. Cell (2006) 5.43
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest (2004) 4.65
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell (2006) 4.64
FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci U S A (2009) 3.99
Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans. Cell (2006) 3.82
Vitamin D receptor as an intestinal bile acid sensor. Science (2002) 3.64
Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol (2003) 3.59
Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem (2002) 3.52
Structural determinants of allosteric ligand activation in RXR heterodimers. Cell (2004) 3.36
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med (2004) 3.17
FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science (2011) 3.16
Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal (2003) 3.14
LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu Rev Physiol (2006) 3.11
Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Cell (2012) 3.07
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A (2006) 3.05
Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes Dev (2012) 2.91
Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A (2004) 2.89
Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab (2008) 2.76
LXRs regulate the balance between fat storage and oxidation. Cell Metab (2005) 2.75
Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol (2010) 2.67
Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci U S A (2002) 2.56
Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab (2007) 2.51
A bile acid-like steroid modulates Caenorhabditis elegans lifespan through nuclear receptor signaling. Proc Natl Acad Sci U S A (2007) 2.50
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A (2003) 2.50
A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab (2005) 2.42
High-throughput real-time quantitative reverse transcription PCR. Curr Protoc Mol Biol (2006) 2.41
Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. Proc Natl Acad Sci U S A (2012) 2.38
Fibroblast growth factor 21: from pharmacology to physiology. Am J Clin Nutr (2009) 2.35
βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism. Cell Metab (2012) 2.27
Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol (2003) 2.26
The liver X receptor gene team: potential new players in atherosclerosis. Nat Med (2002) 2.24
International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol Rev (2006) 2.22
FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat Med (2013) 2.20
27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med (2007) 2.18
A Nuclear Receptor Atlas: macrophage activation. Mol Endocrinol (2005) 2.13
Hormonal control of C. elegans dauer formation and life span by a Rieske-like oxygenase. Dev Cell (2006) 2.11
A Nuclear Receptor Atlas: 3T3-L1 adipogenesis. Mol Endocrinol (2005) 2.06
International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev (2006) 2.04
Identification of a hormonal basis for gallbladder filling. Nat Med (2006) 2.03
A natural product that lowers cholesterol as an antagonist ligand for FXR. Science (2002) 1.99
FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway. Cell Metab (2011) 1.97
Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J Biol Chem (2003) 1.92
FGF21 contributes to neuroendocrine control of female reproduction. Nat Med (2013) 1.89
De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J Biol Chem (2003) 1.89
Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. Mol Endocrinol (2008) 1.85
27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol Endocrinol (2007) 1.75
Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem (2006) 1.72
MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol Endocrinol (2009) 1.71
The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife (2012) 1.69
Nuclear hormone receptor regulation of microRNAs controls developmental progression. Science (2009) 1.69
Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem (2004) 1.57
Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas. Mol Endocrinol (2009) 1.49
Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta. J Biol Chem (2002) 1.48
Liver X receptor alpha is a transcriptional repressor of the uncoupling protein 1 gene and the brown fat phenotype. Mol Cell Biol (2008) 1.47
The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression. J Biol Chem (2003) 1.46
Liver X receptors regulate adrenal cholesterol balance. J Clin Invest (2006) 1.45
The Drosophila orphan nuclear receptor DHR38 mediates an atypical ecdysteroid signaling pathway. Cell (2003) 1.44
Regulation of bile acid synthesis by fat-soluble vitamins A and D. J Biol Chem (2010) 1.40
The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling. Mol Endocrinol (2011) 1.39
Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice. J Clin Invest (2012) 1.38
Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage. Cardiovasc Res (2007) 1.32
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. J Lipid Res (2007) 1.31
Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci U S A (2002) 1.28
Expression of LRH-1 and SF-1 in the mouse ovary: localization in different cell types correlates with differing function. Mol Cell Endocrinol (2003) 1.28
Identification of the nuclear receptor DAF-12 as a therapeutic target in parasitic nematodes. Proc Natl Acad Sci U S A (2009) 1.26
Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism. Diabetes (2008) 1.21
Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology (2007) 1.20
Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer. PLoS Med (2010) 1.19
Expression profiling of nuclear receptors in human and mouse embryonic stem cells. Mol Endocrinol (2009) 1.16
Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions. Mol Endocrinol (2010) 1.15
Nuclear receptors HNF4α and LRH-1 cooperate in regulating Cyp7a1 in vivo. J Biol Chem (2012) 1.13
Pregnane X receptor is a target of farnesoid X receptor. J Biol Chem (2006) 1.13
Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. Am J Physiol Gastrointest Liver Physiol (2012) 1.12
LRH-1 and PTF1-L coregulate an exocrine pancreas-specific transcriptional network for digestive function. Genes Dev (2011) 1.10
The generation of monoclonal antibodies against human peroxisome proliferator-activated receptors (PPARs). J Atheroscler Thromb (2002) 1.08
LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice. J Clin Invest (2010) 1.06
Nuclear receptor regulation of stemness and stem cell differentiation. Exp Mol Med (2009) 1.03
The Rieske oxygenase DAF-36 functions as a cholesterol 7-desaturase in steroidogenic pathways governing longevity. Aging Cell (2011) 1.03
In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue. Mol Endocrinol (2007) 1.03
Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer. Mol Endocrinol (2012) 1.01
Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids. J Med Chem (2007) 0.99
Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes. Mol Endocrinol (2004) 0.97
Synthesis and activity of dafachronic acid ligands for the C. elegans DAF-12 nuclear hormone receptor. Mol Endocrinol (2009) 0.96
Fatty acid regulation of liver X receptors (LXR) and peroxisome proliferator-activated receptor alpha (PPARalpha ) in HEK293 cells. J Biol Chem (2002) 0.92
Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Gastroenterology (2002) 0.92
Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release. Clin Gastroenterol Hepatol (2009) 0.92
Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals. Mol Endocrinol (2003) 0.91
AKR1B7 is induced by the farnesoid X receptor and metabolizes bile acids. J Biol Chem (2010) 0.91
Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis. J Invest Dermatol (2002) 0.91
Nuclear receptors of the enteric tract: guarding the frontier. Nutr Rev (2008) 0.88
Placental expression of the nuclear receptors for oxysterols LXRalpha and LXRbeta during mouse and human development. Anat Rec A Discov Mol Cell Evol Biol (2005) 0.87
Bile Acids as Hormones: The FXR-FGF15/19 Pathway. Dig Dis (2015) 0.86
Interaction between vitamin D receptor and vitamin D ligands: two-dimensional alanine scanning mutational analysis. Chem Biol (2003) 0.85
Structural conservation of ligand binding reveals a bile acid-like signaling pathway in nematodes. J Biol Chem (2011) 0.85
Identification of a liver-specific uridine phosphorylase that is regulated by multiple lipid-sensing nuclear receptors. Mol Endocrinol (2004) 0.85
Structural insights into gene repression by the orphan nuclear receptor SHP. Proc Natl Acad Sci U S A (2013) 0.83